Work

Novel NOTCH1 Effector NFIL3 Is a Therapeutic Target to Combat Drug Resistance and Improve Patient Outcomes in Newly Diagnosed and Relapsed-Refractory Multiple Myeloma

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-205288

Authors: Wen-Hui Cheng, Daniela Simone Maichl, Julius Arthur Kirner, Stefanie Schmidt, Carsten Patrick Ade, Mengshi Yang, Malik Salman Haider, Robert Luxenhofer, Lyudmyla Taranets, Melanie Haffner-Luntzer, Verena Fischer, Anita Ignatius, Nikita Popova, Franziska Jundt

Institutions: University of Würzburg, Universitätsklinikum Würzburg, University of Helsinki, Universitätsklinikum Tübingen, University of Tübingen, Universität Ulm, University Hospital Ulm

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405040257

Cites:

Cited by:

Related to: 10